A Study to Assess the Safety and Pharmacokinetics of GDC-8264 in Combination With Standard of Care in Participants With Acute Graft-Versus-Host Disease (aGVHD)
Clinical trial NCT05673876 · COMPLETED
Trial details
- NCT number
- NCT05673876
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-06
- Primary completion
- 2024-01-15
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.